Retracing events. More definitive answers about the death of a woman in an adeno-associated virus (AAV) gene therapy trial for arthritis must await a meeting of the Recombinant DNA Advisory Committee (RAC) later this month
Nature Biotechnology 2007 September; 25(9): 949
Showing items related by title, author, creator and subject.
NIH recombinant DNA Advisory Committee continues to ponder adverse event associated with AAV gene therapy trial Williams, David A. (2008-03)
Recombinant DNA Advisory Committee, Human Gene Therapy Subcommittee: Minutes of Meeting, 9 Dec 1988 Unknown author (United States. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee, 1989-03)
Minutes of Meeting, 30 Jan 1989, Including Human Gene Therapy Subcommittee Status Report, Proposal to Recommend Amending the Recombinant DNA Advisory Committee Charter, and Proposals to Amend the NIH Guidelines Unknown author (United States. National Institutes of Health. Recombinant DNA Advisory Committee, 1989-06)